Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Bensinger

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Blood|May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trialsSergio Giralt, William Bensinger, Mark Goodman, et al.
Leukemia & Lymphoma|October 6, 2007
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantationGrant E Keeney, Ted A Gooley, Rosalyn N Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myelomaAndrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 8, 2008
NCCN Task Force Report. prevention and management of mucositis in cancer careWilliam Bensinger, Mark Schubert, Kie-Kian Ang, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantationCharles Linker, Paolo Anderlini, Roger Herzig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaVivian G Oehler, Jerald P Radich, Barry Storer, et al.
The New England Journal of Medicine|December 17, 2004
Palifermin for oral mucositis after intensive therapy for hematologic cancersRicardo Spielberger, Patrick Stiff, William Bensinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic MalignanciesManuela Matesan, Darrell R Fisher, Roger Wong, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Blood|May 6, 2003
166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1/2 trialsSergio Giralt, William Bensinger, Mark Goodman, et al.
Leukemia & Lymphoma|October 6, 2007
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantationGrant E Keeney, Ted A Gooley, Rosalyn N Pham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2012
Phase I trial of anti-CS1 monoclonal antibody elotuzumab in combination with bortezomib in the treatment of relapsed/refractory multiple myelomaAndrzej J Jakubowiak, Don M Benson, William Bensinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 8, 2008
NCCN Task Force Report. prevention and management of mucositis in cancer careWilliam Bensinger, Mark Schubert, Kie-Kian Ang, et al.
Blood|May 28, 2009
Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myelomaPaul Richardson, Sundar Jagannath, Mohamad Hussein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2003
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantationCharles Linker, Paolo Anderlini, Roger Herzig, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2013
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendationsSergio Giralt, Luciano Costa, Jeffrey Schriber, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemiaVivian G Oehler, Jerald P Radich, Barry Storer, et al.
The New England Journal of Medicine|December 17, 2004
Palifermin for oral mucositis after intensive therapy for hematologic cancersRicardo Spielberger, Patrick Stiff, William Bensinger, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 15, 2020
Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry Among Hematologic MalignanciesManuela Matesan, Darrell R Fisher, Roger Wong, et al.
Pageof 5